Clinical Research Directory
Browse clinical research sites, groups, and studies.
68Ga-JH12 PET/CT: Dosimetry and Biodistribution Study
Sponsor: First Affiliated Hospital of Fujian Medical University
Summary
68Ga-JH12 is a novel radiotracer targeting C-X-C motif chemokine receptor 4 (CXCR4). In this study, we observed the safety, biodistribution, and radiation dosimetry of 68Ga-JH12 in patients with different types of cancer.
Official title: 68Ga-JH12 PET/CT: Dosimetry and Biodistribution Study in Patients With Various Cancers
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
5
Start Date
2024-11-01
Completion Date
2025-12-31
Last Updated
2024-11-14
Healthy Volunteers
No
Conditions
Interventions
68Ga-JH12
The dose will be 148-222 MBq given intravenously.
Locations (1)
Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China